Pharmaceutical

Lupin, Natco receive US FDA approval for Eribulin Mesyl...

ANDA approval covers Eribulin Mesylate Injection, the bioequivalent of Halaven...

Johnson & Johnson launches VARIPULSE platform for AFib ...

Pulsed Field Ablation technology approved for catheter ablation procedures in p...

Alkem launches semaglutide pre-filled syringes in India

Company introduces single-shot pre-filled syringe format for Type 2 diabetes an...

BMS secures FDA acceptance for Camzyos sNDA

The regulator granted the application priority review for this indication, assig...

Servier to acquire Edgewise’s muscular dystrophy busine...

The value includes a $1.55bn upfront payment and as much as $1.1bn in regulatory...

Financial strategies for uncertain times

Inspite of current geopolitical disruptions,both larger pharma enterprises and ...

The winds reshaping Indian pharma supply chains

As the era of hyper-globalisation appears to have run its course,with geopoliti...

The new playbook for pharma manufacturing

Freight disruption,energy volatility,raw material dependencies and geopolitical...

Resilience: The new mantra for R&D

Geopolitical fragmentation is accelerating the shift toward regional trials, lo...

Quality under pressure: Strengthening continuity amid g...

One of the most persistent risks facing Indian pharma manufacturers is the indu...

Navigating A Vuca World

From supply disruptions to rising operational uncertainty,geopolitics is reshap...

Pfizer launches Elranatamab in India for relapsed or re...

BCMA-directed bispecific antibody is available as a fixed-dose subcutaneous inj...

Aragen manufactures first GMP batches of Daretabart

Technology transfer moves anti-GD2 monoclonal antibody programme from Californi...

Nutrify Today launches Eurasia Sumflex in Tashkent

Three-day event brings together nearly 3,000 stakeholders as Nutrify Today posi...

FDA approves AstraZeneca’s Imfinzi-BCG combination for ...

This marks the first approved immunotherapy combination for this patient segment...

Lilly and Hanmi sign $1.26bn licensing deal for sonefpe...

The agreement covers Hanmi’s candidate that uses its LAPSCOVERY long-acting plat...